The trajectory of the SARS-CoV-2 pandemic in lower latitude, lower income countries including in Sub-Saharan Africa (SSA) remains uncertain. To date, reported case counts and mortality in SSA have lagged behind other geographic regions: all SSA countries, with the exception of South Africa, reported less than 27,000 total cases as of June 2020 ^[@R5]^ ([Table S1](#SD1){ref-type="supplementary-material"}) - totals far less than observed in Asia, Europe, and the Americas ^[@R5],[@R6]^. However, recent increases in reported cases in many SSA countries make it unclear whether the relatively few reported cases to date indicate a reduced epidemic potential or rather an initial delay relative to other regions.

Correlation between surveillance capacity and case counts ^[@R7]^ obscure early trends in SSA ([Figure S1](#SD1){ref-type="supplementary-material"}). Experience from locations in which the pandemic has progressed more rapidly provides a basis of knowledge to assess the relative risk of populations in SSA and identify those at greatest risk. For example, individuals in lower socio-economic settings have been disproportionately affected in high latitude countries,^[@R8],[@R9]^ indicating poverty as an important determinant of risk. Widespread disruptions to routine health services have been reported ^[@R10]-[@R12]^ and are likely to be an important contributor to the burden of the pandemic in SSA ^[@R13]^. The role of other factors from demography ^[@R2]-[@R4]^ to health system context ^[@R14]^ and intervention timing ^[@R15],[@R16]^ is also increasingly well-characterized.

Factors expected to increase and decrease SARS-CoV-2 risk in SSA {#S1}
================================================================

Anticipating the trajectory of ongoing outbreaks in SSA requires considering variability in known drivers, and how they may interact to increase or decrease risk across populations in SSA and relative to non-SSA settings ([Figure 1](#F1){ref-type="fig"}). For example, while most countries in SSA have 'young' populations, suggesting a decreased burden (since SARS-CoV-2 morbidity and mortality increase with age ^[@R2]-[@R4]^), prevalent infectious and non-communicable comorbidities may counterbalance this demographic 'advantage' ^[@R14],[@R17]-[@R19]^. Similarly, SSA countries have health systems that vary greatly in their infrastructure, and dense, resource-limited urban populations may have fewer options for social distancing ^[@R20]^. Yet, decentralized, community-based health systems that benefit from recent experience with epidemic response (e.g., to Ebola ^[@R21],[@R22]^) can be mobilized. Climate is frequently invoked as a potential mitigating factor for warmer and wetter settings ^[@R1]^, including SSA, but climate varies greatly between population centers in SSA and large susceptible populations may counteract any climate forcing during initial phases of the epidemic ^[@R23]^. Connectivity, at international and subnational scales, also varies greatly ^[@R24],[@R25]^ and the time interval between viral introductions and the onset of interventions such as lockdowns will modulate the trajectory ^[@R7]^. Finally, burdens of malnutrition, infectious diseases, and many other underlying health conditions are higher in SSA ([Table S2](#SD1){ref-type="supplementary-material"}), and their interactions with SARS-CoV-2 are, as of yet, poorly understood.

The highly variable social and health contexts of countries in SSA will drive location-specific variation in the magnitude of the burden, the time-course of the outbreak, and options for mitigation. Here, we synthesize the range of factors hypothesized to modulate the potential outcomes of SARS-CoV-2 outbreaks in SSA settings by leveraging existing data sources and integrating novel SARS-CoV-2 relevant mobility and climate-transmission models. Data on direct measures and indirect indicators of risk factors were sourced from publicly available databases including from the WHO, World Bank, UNPOP, DHS, GBD, and WorldPop, and newly generated data sets (see [Table S3](#SD1){ref-type="supplementary-material"} for details). We organize our assessment around two aspects that will shape national outcomes and response priorities in the event of widespread outbreaks: i) the burden, or expected severity of the outcome of an infection, which emerges from age, comorbidities, and health systems functioning, and ii) the rate of spread within a geographic area, or pace of the pandemic.

We group factors that may drive the relative rates of these two features (mortality burden and pace of the outbreak) along six dimensions of risk: (A) Demographic and socio-economic parameters related to transmission and burden, (B) Comorbidities relevant to burden, (C) Climatic variables that may impact the magnitude and seasonality of transmission, (D) Capacity to deploy prevention measures to reduce transmission, (E) Accessibility and coverage of existing healthcare systems to reduce burden, and (F) Patterns of human mobility relevant to transmission ([Table S2](#SD1){ref-type="supplementary-material"}).

National and subnational variability in SSA {#S2}
===========================================

National scale variability in SSA among these dimensions of risk often exceeds ranges observed across the globe ([Figure 2A](#F2){ref-type="fig"}-[D](#F2){ref-type="fig"}). For example, estimates of access to basic handwashing (i.e., clean water and soap ^[@R26]^) among urban households in Mali, Madagascar, Tanzania, and Namibia (62-70%) exceed the global average (58%), but fall to less than 10% for Liberia, Lesotho, Congo DRC, and Guinea-Bissau ([Figure 2D](#F2){ref-type="fig"}). Conversely, the range in the number of physicians is low in SSA, with all countries other than Mauritius below the global average (168.78 per 100,000 population) ([Figure 2A](#F2){ref-type="fig"}). Yet, estimates are still heterogeneous within SSA, with, for example, Gabon estimated to have more than 4 times the physicians of neighboring Cameroon (36.11 and 8.98 per 100,000 population, respectively). This disparity is likely to interact with social contact rates among the elderly in determining exposure and clinical outcomes (e.g., for variation in household size see [Figure 2E](#F2){ref-type="fig"}-[F](#F2){ref-type="fig"}). Relative ranking across variables is also uneven among countries with the result that this diversity cannot be easily reduced (e.g., the first two principal components explain only 32.6%, and 13.1% of the total variance as shown in [Figure S5](#SD1){ref-type="supplementary-material"}), motivating a more holistic approach to projecting burden.

Severity of infection outcome {#S3}
=============================

To first evaluate variation in the burden emerging from the severity of infection outcome, we consider how demography, comorbidity, and access to care might modulate the age profile of SARS-CoV-2 morbidity and mortality ^[@R2]-[@R4]^. Subnational variation in the distribution of high risk age groups indicates considerable variability, with higher burden expected in urban settings in SSA ([Figure 3A](#F3){ref-type="fig"}), where density and thus transmission are likely higher ^[@R27]^.

Comorbidities and access to clinical care also vary across SSA (e.g., for diabetes prevalence and hospital bed capacity see [Figure 3B](#F3){ref-type="fig"}). In comparison to settings where previous SARS-CoV-2 infection fatality ratio (*IFR*) estimates have been reported, mortality due to noncommunicable diseases in SSA increases more rapidly with age ([Figure S6](#SD1){ref-type="supplementary-material"}). Consequently, we explore scenarios where the SARS-CoV-2 *IFR* increases more rapidly with age than the baseline expected from other settings. Small shifts (e.g., of 2-10 years) in the *IFR* profile result in large effects on expected mortality for a given level of infection. For example, Chad, Burkina Faso, and the Central African Republic, while among the youngest SSA countries, have a relatively high prevalence of diabetes and relatively low density of hospital beds. A five year shift younger in the *IFR* by age profile of SARS-CoV-2 in these settings would result in nearly a doubling of mortality, to a rate that would exceed the majority of other, 'older' SSA countries at the unshifted baseline ([Figure 3C](#F3){ref-type="fig"}, see [supplement](#SD1){ref-type="supplementary-material"} for details of methods). Although there is greater access to care in older populations by some metrics ([Figure 2A](#F2){ref-type="fig"}, correlation between age and the number of physicians per capita, *r* = 0.896, *p* \< 0.001), access to clinical care is highly variable overall ([Figure 3D](#F3){ref-type="fig"}) and maps poorly to indicators of comorbidity ([Figure 3E](#F3){ref-type="fig"}). Empirical data are urgently needed to assess the extent to which the *IFR*-age-comorbidity associations observed elsewhere are applicable to SSA settings with reduced access to advanced care. Yet both surveillance and mortality registration ^[@R28]^ are frequently underresourced in SSA, complicating both evaluating and anticipating the burden of the pandemic, and underscoring the urgency of strengthening existing systems ^[@R22]^.

Pandemic pace {#S4}
=============

Next, we turn to the pace of the pandemic within each country. The frequency of viral introduction to each country, likely governed by international air travel in SSA ^[@R29]^, determines both the timing of the first infections and the number of initial infection clusters that can seed subsequent outbreaks. The relative importation risk among SSA cities and countries was assessed by compiling data from 108,894 flights arriving at 113 international airports in SSA from January to April 2020 ([Figure 4A](#F4){ref-type="fig"}), stratified by the SARS-CoV-2 status at the departure location on the day of travel ([Figure 4B](#F4){ref-type="fig"}). A small subset of SSA countries received a disproportionately large percentage (e.g., South Africa, Ethiopia, Kenya, Nigeria together contribute 47.9%) of the total travel from countries with confirmed SARS-CoV-2 infections, likely contributing to variation in the pace of the pandemic across settings ^[@R29],[@R30]^.

Once local chains of infection are established, the rate of spread within countries will be shaped by efforts to reduce spread, such as handwashing ([Figure 2D](#F2){ref-type="fig"}), population contact patterns including mobility and urban crowding ^[@R27]^ (e.g., [Figure 2C](#F2){ref-type="fig"}), and potentially the effect of climatic variation ^[@R1]^. Where countries fall across this spectrum of pace will shape interactions with lockdowns and determine the length and severity of disruptions to routine health system functioning.

Subnational connectivity varies greatly across SSA, both between subregions of a country and between cities and their rural periphery (e.g., as indicated by travel time to the nearest city over 50,000 population, [Figure 4C](#F4){ref-type="fig"}). As expected, in stochastic simulations using estimates of viral transmission parameters and mobility (assuming no variation in control efforts, see methods), a smaller cumulative proportion of the population is infected at a given time in countries with larger populations in less connected subregions ([Figure 4D](#F4){ref-type="fig"}). At the national level, susceptibility declines more slowly and more unevenly in such settings (e.g., Ethiopia, South Sudan, Tanzania) due to a lower probability of introductions and re-introductions of the virus locally; an effect amplified by lockdowns. It remains unclear whether the more prolonged, asynchronous epidemics expected in these countries or the overlapping, concurrent epidemics expected in countries with higher connectivity (e.g. Malawi, Kenya, Burundi) will be a greater stress to health systems. Outbreak control efforts are likely to be further complicated during prolonged epidemics if they intersect with seasonal events such as temporal patterns in human mobility ^[@R31]^ or other infections (e.g., malaria).

Turning to climate, despite extreme variation among cities in SSA ([Figure 4E](#F4){ref-type="fig"}), large epidemic peaks are expected in all cities ([Figure 4F](#F4){ref-type="fig"}), even from models where transmission rate significantly declines in warmer, more humid settings. In the absence of interventions, with transmission rate modified by climate only, peak timing varies only by 4-6 weeks with peaks generally expected earlier in more southerly, colder, drier, cities (e.g., Windhoek and Maseru) and later in more humid, coastal cities (e.g., Bissau, Lomé, and Lagos). Apart from these slight shifts in timing, large susceptible populations overwhelm the effects of climate ^[@R23]^, and earlier suggestions that Africa's generally more tropical environment may provide a protective effect^[@R1]^ are not supported by evidence.

Context-specific preparedness in SSA {#S5}
====================================

Our synthesis emphasizes striking country to country variation in drivers of the pandemic in SSA ([Figure 2](#F2){ref-type="fig"}), indicating variation in the burden ([Figure 3](#F3){ref-type="fig"}) and pace ([Figure 4](#F4){ref-type="fig"}) is to be expected even across low income settings. As small perturbations in the age profile of mortality could drastically change the national level burden in SSA ([Figure 3](#F3){ref-type="fig"}), building expectations for the risk for each country requires monitoring for deviations in the pattern of morbidity and mortality over age. Transparent and timely communication of these context-specific risk patterns could help motivate population behavioral changes and guide existing networks of community case management.

Because the largest impacts of SARS-CoV-2 outbreaks may be through indirect effects on routine health provisioning, understanding how existing programs may be disrupted differently by acute versus longer outbreaks is crucial to planning resource allocation. For example, population immunity will decline proportionally with the length of disruptions to routine vaccination programs ^[@R31]^, resulting in more severe consequences in areas with prolonged epidemic time courses.

Others have suggested that this crisis presents an opportunity to unify and mobilize across existing health programs (e.g., for HIV, TB, Malaria, and other NCDs) ^[@R22]^. While this may be a powerful strategy in the context of acute, temporally confined crises, long term distraction and diversion of resources ^[@R32]^ may be harmful in settings with extended, asynchronous epidemics. A higher risk of infection among healthcare workers during epidemics ^[@R33],[@R34]^ may amplify this risk.

Due to the lag relative to other geographic regions, many SSA settings retain the opportunity to prepare for and intervene in the earlier epidemic phases via context-specific deployment of both routine and pandemic related interventions. As evidenced by failures in locations where the epidemic progressed rapidly (e.g., USA), effective governance and management prior to reaching large case counts is likely to yield the largest rewards. Mauritius ^[@R35]^ and Rwanda ^[@R36]^, for example, have reported extremely low incidence thanks in part to a well-managed early response.

Conclusions {#S6}
===========

The burden and time-course of SARS-CoV-2 is expected to be highly variable across sub-Saharan Africa. As the outbreak continues to unfold, critically evaluating this mapping to better understand where countries lie in terms of their relative risk (e.g., see [Figure 5](#F5){ref-type="fig"}) will require increased surveillance, and timely documentation of morbidity and mortality over age. Case counts are rising across SSA, but variability in testing regimes makes it difficult to compare observations to date with expectations in terms of pace ([Figure S7](#SD1){ref-type="supplementary-material"}). The potential to miss large clusters of cases (in contexts with weaker surveillance), combined with the potential that large areas remain unreached by the pandemic for longer (as a result of slower 'pace'), indicate that immunological surveys are likely a powerful lens for understanding the landscape of population risk ^[@R37]^. When considering hopeful futures with the possibility of a SARS-CoV-2 vaccine, it is imperative that vaccine distribution be equitable, and in proportion with need. Understanding factors that both drive spatial variation in vulnerable populations and temporal variation in pandemic progression could help approach these goals in SSA.
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![Hypothesized modulators of relative SARS-CoV-2 epidemic risk in sub-Saharan Africa\
Factors hypothesized to increase (red) or decrease (blue) mortality burden or epidemic pace within sub-Saharan Africa, relative to global averages, are grouped in six categories or dimensions of risk (A-F). In this framework, epidemic pace is determined by person to person transmissibility (which can be defined as the time-varying effective reproductive number, *R~t~)* and introduction and geographic spread of the virus via human mobility.\
SARS-CoV-2 mortality (determined by the infection fatality ratio, *IFR*) is modulated by demography, comorbidities (e.g., non-communicable diseases (NCDs)), and access to care. Overall burden is a function of direct burden and indirect effects due to, for example, disruptions in health services such as vaccination and infectious disease control. [Table S2](#SD1){ref-type="supplementary-material"} contains details and the references used as a basis to draw the hypothesized modulating pathways.](nihpp-2020.07.23.20161208-f0001){#F1}

![Variation among sub-Saharan African countries in select determinants of SARS-CoV-2 risk\
**A-D**: At right, SSA countries are ranked from least to greatest for each indicator; bar color shows population age structure (% of the population above age 50). Solid horizontal lines show the global mean value; dotted lines show the mean among SSA countries. At left, boxplots show median and interquartile range, grouped by geographic region, per WHO: sub-Saharan Africa (SSA); Americas Region (AMR); Eastern Mediterranean Region (EMR); Europe Region (EUR); Southeast Asia Region (SEA); Western Pacific Region (WPR).\
**E-F:** Dot size shows mean household (HH) size for HHs with individuals over age 50; dashed lines show median value among SSA countries; quadrants of greatest risk are outlined in red (e.g., fewer physicians and greater age standardized Chronic Obstructive Pulmonary Disease (COPD) mortality). See [Table S3](#SD1){ref-type="supplementary-material"}, [Figure S3](#SD1){ref-type="supplementary-material"}, and the \[[SSA-SARS-CoV-2-tool]{.ul}\] for full description and visualization of all variables.](nihpp-2020.07.23.20161208-f0002){#F2}

![Variation in expected burden for SARS-CoV-2 outbreaks in sub-Saharan Africa\
**A**: Expected mortality in a scenario where cumulative infection reaches 20% across age groups and the infection fatality ratio (*IFR*) curve is fit to existing age-stratified *IFR* estimates (see methods, [Table S4](#SD1){ref-type="supplementary-material"}). **B**: National level variation in comorbidity and access to care variables, for e.g., diabetes prevalence among adults and the number of hospital beds per 100,000 population for sub-Saharan African countries. **C**: The range in mortality per 100,000 population expected in scenarios where cumulative infection rate is 20% and *IFR* per age is the baseline (black) or shifted 2, 5, or 10 years younger (gray). Inset, the *IFR* by age curves for each scenario.\
**D-E**: Select national level indicators; estimates of reduced access to care (e.g., fewer hospitals) or increased comorbidity burden (e.g., higher prevalence of raised blood pressure) shown with darker red for higher risk quartiles (see [Figure S4](#SD1){ref-type="supplementary-material"} for all indicators). Countries missing data for an indicator (NA) are shown in gray. For comparison between countries, estimates are age-standardized where applicable (see [Table S3](#SD1){ref-type="supplementary-material"} for details). See the \[[SSA-SARS-CoV-2-tool]{.ul}\] for high resolution maps for each variable and scenario.](nihpp-2020.07.23.20161208-f0003){#F3}

![Variation in connectivity and climate in sub-Saharan Africa and expected effects on SARS-CoV-2\
**A:** International travelers to sub-Saharan Africa (SSA) from January to April 2020, as inferred from the number of passenger seats on arriving aircraft. **B**: For the four countries with the most arrivals, the proportion of arrivals by month coming from countries with 0, 1-100, 101-1000, and 1000+ reported SARS-CoV-2 infections at the time of travel (see [Table S5](#SD1){ref-type="supplementary-material"} for all others).\
**C**: Connectivity within SSA countries as inferred from average population weighted mean travel time to the nearest urban area greater than 50,000 population.\
**D**: Mean travel time at the national level and variation in the fraction of the population expected to be infected (*I/N*) in the first year from stochastic simulations (see methods). **E**: Climate variation across SSA as shown by seasonal range in specific humidity, *q* (g/kg) (max average *q* - min average *q*). Circles show peak proportion infected. **F:** The effect of local seasonality in SSA cities on outbreaks (*I/N* over time) in susceptible populations beginning in March 2020 (see methods).](nihpp-2020.07.23.20161208-f0004){#F4}

![Expected pace versus expected burden at the national level in SARS-CoV-2 outbreaks in sub-Saharan Africa\
Countries are colored by with respect to indicators of their expected epidemic pace (using as an example subnational connectivity in terms of travel time to nearest city) and potential burden (using as an example the proportion of the population over age 50).\
**A:** In pink, countries with less connectivity (i.e., less synchronous outbreaks) relative to the median among SSA countries; in blue, countries with more connectivity; darker colors show countries with older populations (i.e., a greater proportion in higher risk age groups).\
**B**: Dotted lines show the median; in the upper right, in dark pink, countries are highlighted due to their increased potential risk for an outbreak to be prolonged (see metapopulation model methods) and high burden (see burden estimation methods).](nihpp-2020.07.23.20161208-f0005){#F5}

[^1]: Author contributions

    *Conceptualization*: BLR, AA, REB, MB, WWD, KM, IFM, NVM, AR, MR, JR, TR, FR, WY, BTG, CJT, CJEM; *Data curation*: BLR, MR, MB, WWD, WY; *Formal analysis*: BLR, AA, MB, MR, REB; *Methodology*: BLR, MR, MB, REB, CJEM, BTG; *Software and Shiny app online tool*: BLR, MR, MB, REB, WY; *Visualization*: BLR, MR, MB, REB, WY; *Writing* -- original draft: BLR, CJEM; *Writing -- reviewing and editing*: BLR, AA, REB, MB, WWD, KM, IFM, NVM, AR, MR, JR, TR, FR, WY, BTG, CJT, CJEM
